Objective: To assess the performance of a computer-assisted diagnosis (CAD) 
iNtRODUCtiON
Clinical presentation of pulmonary embolism (PE) can range from asymptomatic to immediate death. PE can occur rapidly and unpredictably and is sometimes difficult to diagnose. Untreated symptomatic PE is associated with a high mortality and thus prompt and accurate diagnosis is needed. 1 Computed tomography (CT) angiography is the first-line imaging modality to detect PE. [2] [3] [4] It can also detect other thoracic pathologies such as pleural effusion, pulmonary infiltration, and atelectasis. Multidetector CT (MDCT) increases sensitivity and specificity of PE detection, especially for smaller pulmonary artery branches, [5] [6] [7] due to its fast subsecond acquisition, thin collimation, and high spatial resolution.
T h e P r o s p e c t i v e I n v e s t i g a t i o n o f P u l m o n a r y Embolism Diagnosis Group recommends the use of CT angiography to detect PE in patients positive for D-dimers with a low-to-moderate clinical probability, and in patients with a high clinical probability. 3, 8, 9 According to the British Thoracic Society, additional diagnostic test is not necessary after a negative MDCT and no anticoagulation is needed. 10 In MDCT, thin collimation with 400-800 sections leads to a considerable increase in image data. This may lead to false-negative diagnosis under emergency conditions. 11, 12 Computer-assisted diagnosis (CAD) can reduce false-negative diagnosis, especially in patients with severe pre-existing cardiorespiratory disease. 13, 14 Nonetheless, CAD has a highly variable sensitivity of 31% to 92% and specificity of 80% to 92 %, [15] [16] [17] although it has a second-reader benefit for detection of individual emboli. 16, 17 This study aimed to assess the performance of a CAD software in detecting PE and the role of CAD as a second reader.
MEtHODS
Institutional review board approval was waived for this study. The research protocol was conducted in compliance with Declaration of Helsinki. We retrospectively reviewed CT data of 100 consecutive patients (mean ± standard deviation [SD] age, 60.7 ± 18.3 years) with clinically suspected PE who underwent MDCT angiography of the pulmonary arteries according to the standard protocol. 18 Not all patients had been examined for the blood D-dimer level. MDCT angiography was performed on a 64-detector-row CT through a cranio-caudal direction during inspiratory breath-hold ( Table 1 ). The diagnosis ('initial read') had been made in consensus by two out of 10 radiologists with ≥3 years of experience.
The original CT data were retrieved and transferred to a standard workstation with a viewing software and a CAD software (Siemens Medical Solutions, Malvern [PA], USA). Two other experienced chest radiologists reviewed all CAD markings to determine the ground truth for CAD and the standard of reference (final diagnosis) in consensus. The markings were categorised as true or false positive. For true positive, the involved vessel segment was classified as lobar, segmental, and subsegmental.
The CAD software ran the following key steps: lung
（22.2%）檢測不到肺栓子。初次閱讀和CAD軟件的靈敏度分別為84%和81%、特異度分別為100% 和16%、陽性預測值分別為100%和31%、陰性預測值分別為93%和65%。 結論：CAD軟件可作為第二評估者，但不應被用作獨立診斷工具；所有的MDCT應由放射科醫師審 查。 segmentation, candidate generation, feature extraction, and false-positive filtering reduction. 19 Background noise (for evaluation of image quality) was based on the attenuation (in Hounsfield units) at a region of interest of approximately 1 cm 2 within the surrounding air in front of the patient.
Performance of the CAD software and initial radiologists in each patient was compared with the standard of reference (final diagnosis). Sensitivity, specificity, and positive and negative predictive values and their 95% confidence intervals (CI) were calculated. A p value of <0.05 was considered statistically significant.
RESULtS
The mean value of image noise was 12.2 (SD, 2.8; range, 7-19) Hounsfield units. There was no effective limitation due to varying image quality. 20 In the initial read, 27 and 73 patients were positive and negative for PE, respectively. Based on the standard of reference, five (6.8%) of the 73 patients negative for PE were determined to be false negative and the remaining 68 were true negative. The CAD software marked 86 and 14 patients with and without pulmonary emboli, respectively. Based on the standard of reference, 26 were true positive, 57 were false positive, 11 were true negative, and 6 were false negative (Table 2) .
Respectively for the initial read and CAD software, sensitivity was 84% (95% CI = 67-95%) and 81% (95% CI = 64-93%), specificity was 100% (95% CI = 95-100%) and 16% (95% CI = 8-27%), positive predictive value was 100% (95% CI = 95-100%) and 31% (95% CI = 22-42%), and negative predictive value was 93% (95% CI = 85-98%) and 65% (95% CI = 38-86%).
The CAD software detected pulmonary emboli in five (6.9%) of 73 patients who were initially read as negative. The emboli were located at the subsegmental level of the right inferior (n = 1), left inferior (n = 1) and left superior (n = 1) lobe as well as the segmental level of the right inferior (n = 1) and left superior (n = 1) lobe (Figures 1 and 2 ). The patient with a segmental PE in the left inferior lobe also showed signs of right ventricular dysfunction (Figure 3) . The other four patients were haemodynamically stable with absence of morphological features of right heart failure; they did not receive any treatment.
The CAD software failed to detect pulmonary emboli in 6 (22.2%) of 27 patients who were initially read as positive. The emboli were located at the central (n = 3), segmental (n = 2), and subsegmental (n = 1) levels. There were a mean of 3.8 false-positive CAD markers per patient, mainly caused by vessel walls, pericardium, pulmonary consolidation, or the lobe of the azygous vein ( Figure 4 ).
DiSCUSSiON
PE may result in morbidity and mortality if left untreated; prompt and accurate diagnosis is necessary. 21 Pulmonary MDCT angiography has been the firstline imaging modality for patients with suspected PE. [2] [3] [4] 22 Nonetheless, smaller pulmonary emboli especially at segmental and subsegmental arteries can be easily missed under emergency conditions owing to the large amount of data acquired by MDCT with thin collimation. The use of a CAD software as a second reader improves the sensitivity for detection of individual pulmonary emboli that may be missed by radiologists, especially in segmental and subsegmental arteries. 16, 17 Patients diagnosed with PE should immediately be started on intravenous anticoagulation unless contraindicated to decrease the thromboembolic burden. Hospitalisation with bed rest for 24 to 48 hours is recommended. 1 Nonetheless, it remains controversial about the necessity for treatment of small emboli at a subsegmental level. 23 Small peripheral PE may be clinically relevant in patients with restricted cardiorespiratory reserve, and may lead to chronic thromboembolic pulmonary hypertension if untreated. 24 The presence of small peripheral emboli suggests the presence of a venous thrombosis in the lower extremities or pelvis, and thus an aggressive workup. Patients with asymptomatic isolated subsegmental pulmonary emboli should be treated. 12 The CAD software can detect missed emboli but should not be used as a stand-alone tool for diagnosis. The algorithm of this software was not intended to detect central PE, hence the relatively high rate (18.8%) of false negative. The mean of 3.8 false-positive markers per patient is in line with that reported in one study. 17 The main limitation of our study was that secondary disorders that might have led to false negative initially were not analysed. Data were analysed retrospectively and may not represent those obtained during daily routine imaging and reading. In addition, the two experienced radiologists who reviewed the CAD markers provided no absolute confidence in CAD marker interpretation.
CONCLUSiON
CAD software may detect PE that are initially missed, but it also produces false-negative and false-positive results. It should not be used as a stand-alone tool for diagnosis; all MDCT should be reviewed by a radiologist.
